News & Blog

April 12, 2022 | Press Release
Aspen Neuroscience Launches First Patient Screening Study for Planned Clinical Trial of Personalized Cell Replacement in Parkinson’s Disease
March 01, 2022 | In The News
ALS News Today: ProJenX Launches, Will Develop ALS Therapy Prosetin
March 01, 2022 | Press Release
ProJenX Announces First Person Dosed in Phase 1 Study of Prosetin
February 16, 2022 | Press Release
ProJenX launches to advance novel, targeted therapies for ALS and other brain diseases
January 12, 2022 | In The News
MEC SAB in the News: Fastest DNA sequencing technique helps undiagnosed patients find answers in mere hours
December 22, 2021 | Blog Post
Neuroscience Medicine: A New Frontier
November 23, 2021 | Blog Post
Partnerships are Key to Driving Innovation and Value in Drug Development: A View from the Top
November 16, 2021 | In The News
Endpoints News: Out to prove the next big I/O target, Immunitas’ chief dealmaker steps up to CEO role
November 16, 2021 | Press Release
Immunitas Therapeutics Names Amanda Wagner as CEO
November 09, 2021 | Blog Post
Artificial Intelligence and Drug Discovery: Cutting Edge AI to Address Pediatric Diseases